Need a report that reflects how COVID-19 has impacted this market and its growth?
The United States bariatric surgery market was valued at USD 668.78 million in 2021 and is expected to project growth at a CAGR of 8.1% during the forecast period. There are certain factors propelling the growth of the market, including increasing obesity patients, growing government initiatives to curb obesity, and a rising prevalence rate of type 2 diabetes and heart diseases in the country.
As per United States National Health Statistics Reports published in June 2021, among adults aged 20 and over, the prevalence of obesity was 41.9%, severe obesity was 9.2%, and diabetes was 14.8%. The increase in the prevalence of obesity among the population is expected to drive the bariatric surgery market in the United States. Furthermore, the presence of established healthcare infrastructure along with the presence of a large number of market players in the country is expected to boost market growth over the forecast period. For instance, in September 2020, Ethicon, part of Johnson & Johnson Medical Devices Companies, launched ECHELON ENDOPATH Staple Line Reinforcement (SLR), a buttressing device designed to reduce potential complications during bariatric procedures.
Scope of the report
As per the scope of the report, bariatric surgery or weight loss surgery is used as one of the major treatment procedures for treating obesity. It is generally the last option for patients who have failed to lose weight by several other means. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or by using a gastric band. The United States Bariatric Surgery Market is segmented by the device (Assisting Devices, and Implantable Devices). The report offers the value (in USD million) for the above segments.
Key Market Trends
Closure Device Segment is Expected to Register a High CAGR in the Assisting Device Segment
Closure devices are used to reconnect tissues during surgical procedures, also for closing incisions made by trocars. The laparoscopic port closure device helps obese patients undergoing bariatric procedures and surgeries by successfully and safely closing port sites.
The closure devices segment is expected to show high growth, as they are widely used in minimally invasive surgeries, where immediate closure of very small incisions made at the time of surgical procedures is required.
In May 2021, Standard Bariatrics announced the launch of its novel Titan SGS stapling technology, specifically designed for bariatric sleeve surgery, also the device has been cleared by the United States Food and Drug Administration (FDA). These new product launches by major players for new closure devices are propelling the studied market growth.
In 2019, in the United States, the adult obesity rates exceeded 35% in nine states, 30% in 31 states, and 25% in 48 reports the Behavioral Risk Factor Surveillance System (BRFSS) 2019 data. According to the same source, Mississippi and West Virginia carried the highest adult obesity rate at 39.5% and Colorado had the lowest rate at 23%. Also, the reports summed up by Trust for America's Health organization, in 2020 the adult obesity rate was at 42.4%, the first time the national rate has passed the 40% mark and national adult obesity rate has increased by 26% since 2008. These increasing burden of obesity among population is increasing the demand of bariatric surgeries and these increases the demand for more closure devices to be used for bariatric surgeries and contribute to the faster growth of this segment.
To understand key trends, Download Sample Report
The United States bariatric surgery market is moderately consolidated competitive with the presence of major players, such as Medtronic PLC, Johnson and Johnson (Ethicon Inc.), Apollo Endo-surgery Inc., Aspire Bariatrics Inc Intuitive Surgical Inc., B. Braun Melsungen AG, Olympus Corporation, The Cooper Companies, Conmed Corporation among others. The market is also inclusive of the smaller players that hold a substantial market share. With the growing medical device market, it is expected that a few more new players will be penetrating the market in the coming future.
Johnson and Johnson (Ethicon Inc)
Apollo Endosurgery, Inc
Aspire Bariatrics Inc.
Intuitive Surgical Inc
- In September 2021, Olympus launched the POWERSEAL advanced bipolar surgical energy devices to Strengthen its Surgical Portfolio. The POWERSEAL devices can be used in numerous forms of surgical intervention including bariatric surgical procedures.
- In June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies launched the ENSEAL X1 Curved Jaw Tissue Sealer for colorectal, gynecological, bariatric surgery, and thoracic procedures.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Obesity Patients
4.2.2 Rising Prevalence Rate of Type 2 Diabetes and Heart Diseases
4.2.3 Growing Government Initiatives to Curb Obesity
4.3 Market Restraints
4.3.1 High Cost of Surgery
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Device
5.1.1 Assisting Devices
184.108.40.206 Suturing Device
220.127.116.11 Closure Device
18.104.22.168 Stapling Device
22.214.171.124 Other Assisting Devices
5.1.2 Implantable Devices
126.96.36.199 Gastric Bands
188.8.131.52 Electrical Stimulation Devices
184.108.40.206 Gastric Balloons
220.127.116.11 Gastric Emptying
18.104.22.168 Other Devices
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Johnson and Johnson (Ethicon Inc)
6.1.3 Apollo Endosurgery Inc.
6.1.4 Aspire Bariatrics Inc.
6.1.5 Intuitive Surgical Inc.
6.1.6 B. Braun Melsungen AG
6.1.7 Olympus Corporation
6.1.8 The Cooper Companies
6.1.9 Conmed Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Frequently Asked Questions
What is the study period of this market?
The United States Bariatric Surgery Market market is studied from 2019 - 2027.
What is the growth rate of United States Bariatric Surgery Market?
The United States Bariatric Surgery Market is growing at a CAGR of 8.1% over the next 5 years.
What is United States Bariatric Surgery Market size in 2019?
The United States Bariatric Surgery Market is valued at 668 Million USD in 2019.
Who are the key players in United States Bariatric Surgery Market?
Medtronic PLC, Johnson and Johnson (Ethicon Inc), Apollo Endosurgery, Inc, Aspire Bariatrics Inc., Intuitive Surgical Inc are the major companies operating in United States Bariatric Surgery Market.